MarketPeel
Insider Trading Intelligence
YP

Yale Podnos

TOI
CHIEF MEDICAL OFFICER · ONCOLOGY INSTITUTE, INC. · CIK 0001891104
FILING MIX · LIFETIME59%/41%
BUYS
23
SELLS
16
TOTAL VALUE
$223.1K
COMPANIES
1
ACTIVE SINCE
Nov 2021
HOLDINGS NOW
259,527
AVG SELL PX
$3.76
TRADE KIND
SHOWING 39 / 39
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Yale Podnos, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-18.14%+0.35%-18.49%-18.49%
14d1+100.00%-28.92%-0.82%-28.10%-28.10%
30d1+100.00%-54.81%-2.22%-52.59%-52.59%
60d1+100.00%-16.67%+0.46%-17.13%-17.13%
90d1+100.00%-25.49%+4.07%-29.57%-29.57%
180d1+100.00%-77.94%+4.52%-82.46%-82.46%
1y1+0.00%+8.82%+14.62%-5.80%-5.80%
2y1+100.00%-88.47%+53.29%-141.76%-141.76%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TOI · 259,527 shares · as of Jun 8, 2026
075,239150,478225,717300,95620222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 23 buys / 16 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TOI
ONCOLOGY INSTITUTE, INC.
SALE10b5-1
10b5-1 plan
23,451$5.38$126.1K259,527Jun 8, 2026Jun 9, 2026View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
1,805$4.47$8.1K282,978May 21, 2026May 22, 2026View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
66,446300,956Mar 27, 2026Apr 1, 2026View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
16,173$3.07$49.7K284,783Mar 27, 2026Apr 1, 2026View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
3,420$3.59$12.3K234,510Mar 17, 2026Mar 18, 2026View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
2,086237,930Nov 17, 2025Nov 19, 2025View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
306234,642Nov 12, 2025Nov 14, 2025View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
1,202235,844Nov 12, 2025Nov 14, 2025View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
1,801$2.68$4.8K234,336May 21, 2025May 22, 2025View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
157,088236,137Mar 31, 2025Apr 2, 2025View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
Chief Medical Officer
4,528$0.13$5664,528Mar 26, 2025Mar 28, 2025View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASE
Chief Medical Officer
9,056$1.04$9.4K79,049Mar 26, 2025Mar 28, 2025View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
2,975$0.89$2.6K69,993Mar 19, 2025Mar 20, 2025View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
1,709$0.14$23274,261Nov 20, 2024Nov 21, 2024View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
1,026$0.14$14072,968Nov 20, 2024Nov 21, 2024View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
267$0.14$3673,994Nov 20, 2024Nov 21, 2024View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
11,35993,009Nov 12, 2024Nov 18, 2024View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
17,03975,970Nov 12, 2024Nov 18, 2024View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
43,82543,825May 21, 2024May 23, 2024View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
17,530104,368May 21, 2024May 23, 2024View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
1,530$2.19$3.4K86,838Nov 21, 2023Nov 22, 2023View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
238$2.39$56890,228Nov 14, 2023Nov 16, 2023View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
1,860$2.39$4.4K88,368Nov 14, 2023Nov 16, 2023View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
83,04783,047Mar 17, 2023Mar 21, 2023View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
33,21990,466Mar 17, 2023Mar 21, 2023View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
71,89571,895Nov 17, 2022Nov 21, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
14,16457,247Nov 17, 2022Nov 21, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
199$2.03$40443,083Nov 15, 2022Nov 17, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
SALE
Chief Medical Officer
199$2.03$40443,083Nov 15, 2022Nov 22, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
12,72043,282Mar 21, 2022Mar 23, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
2,16430,562Mar 21, 2022Mar 23, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
1,7571,757Mar 21, 2022Mar 23, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
10,33010,330Mar 21, 2022Mar 23, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
64,56764,567Mar 21, 2022Mar 29, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
10,98410,984Mar 21, 2022Mar 29, 2022View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
77,91677,916Nov 12, 2021Nov 16, 2021View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
68,20868,208Nov 12, 2021Nov 16, 2021View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
11,35911,359Nov 12, 2021Nov 16, 2021View →
TOI
ONCOLOGY INSTITUTE, INC.
PURCHASEGRANT
Stock grant
17,03917,039Nov 12, 2021Nov 16, 2021View →
Other insiders · TOI
Loading peer insiders…
About this filer
CIK 0001891104
ROLE
Chief Medical Officer
PRIMARY
TOI
COMPANIES
1
ACTIVE SINCE
Nov 2021
MARKETPEEL · /INSIDER/0001891104DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback